In a recent article from @Reuters' Amina Niasse and @Sripootweets, @SmeadCap Founder and CIO Bill Smead provides his perspective on UnitedHealth CEO Stephen Hemsley. Read here:

The U.S. Food and Drug Administration approved Astellas' gastric cancer therapy, the health regulator's website showed on Friday. https://t.co/ox93sfLsfi

CVS Health on Friday named company veteran David Joyner as new CEO, succeeding Karen Lynch who stepped down from the helm of the struggling healthcare giant after an agreement with the board. https://t.co/Jw7IQuTOLF

Humana's shares slumped 15% on Wednesday as the health insurer said enrollments in its top-rated Medicare insurance plans dropped sharply, casting a cloud over the company's 2026 revenue and bonus payments. https://t.co/D3DVVCKACX

Smaller rivals to $UNH's Change Healthcare say they are signing longer-term contracts with hospitals and other customers who had temporarily switched after the Feb hack. @LeroyLeo7 and I report for @Reuters Read here:

U.S. drugstore chain Rite Aid said on Tuesday it would operate as a private company as it successfully completed its financial restructuring and emerged from Chapter 11 bankruptcy. https://t.co/isggbxfSu0

Elevance Health signaled medical costs would remain high this year as the insurer expects more claims in the second half from members enrolled in its government-backed Medicaid plans, sending its shares down nearly 7% on Wednesday. https://t.co/7go5uO66gi

The tiny wires of Neuralink's brain chip implant used in the first participant in a trial run by Elon Musk's company have become "more or less very stable", a company executive said on Wednesday. https://t.co/ftmgrQBMRP

The U.S. Federal Trade Commission is planning to sue UnitedHealth , Cigna and CVS Health over their tactics as middlemen in negotiating prices for drugs including insulin, a person familiar with the matter said on Wednesday. https://t.co/FIiIdYXvDy

Pfizer said on Thursday it would conduct studies in the second-half of 2024 on a reworked, once-a-day version of its experimental obesity pill, danuglipron. https://t.co/FKVfEj0Idm

Medical diagnostic tech is making the leap to elite sports. With @Sripootweets #cgm #continuousglucosemonitoring #glucose https://t.co/AsLxYgFkN4

The added benefits of the extremely popular #wegovy and #zepbound may help convince more men to use them, several doctors told @BhanviSatija and I. Read more at @Reuters to find out the reasons behind this. https://t.co/Yl3Sqw56AS #weightlossdrugs

UnitedHealth is expected to record higher medical costs in its first earnings report since a cyberattack disrupted its technology systems including those that manage prescription and medical claims, analysts said. https://t.co/mXEMIRDxqB

The World Health Organization (WHO) on Tuesday classified the JN.1 coronavirus strain as a "variant of interest" and said current evidence shows risk to public health was low from the strain. https://t.co/wPsH26YqZm

The U.S. Food and Drug Administration (FDA) said on Tuesday it has approved the first test to assess if there is a risk of opioid use addiction in certain individuals. https://t.co/mBh6bqLNp4

Novo Nordisk said on Monday the U.S. Food and Drug Administration (FDA) had approved its therapy to treat a rare genetic condition that affects the kidneys.

Japan's Takeda Pharmaceutical said on Monday it will voluntarily withdraw its lung cancer therapy from the United States, where it had received an accelerated approval in 2021, after it failed to meet the main goal in a late-stage study.

No fresh cases of the deadly Nipah virus have been detected since Sept. 15 in India's southern state of Kerala, the World Health Organization (WHO) said on Tuesday.

Insulet Corp said on Tuesday Wayde McMillan would step down as the medical device maker's chief financial officer, effective Oct. 20, to join 3M's healthcare business.

The U.S. Food and Drug Administration on Tuesday authorized an updated version of Novavax's protein-based COVID-19 vaccine for emergency use in individuals aged 12 years and older, the health regulator said.